The Legumain Protease-Activated Auristatin Prodrugs Suppress Tumor Growth and Metastasis without Toxicity
作者:Krishna Mohan Bajjuri、Yuan Liu、Cheng Liu、Subhash C. Sinha
DOI:10.1002/cmdc.201000478
日期:2011.1.3
Tumor exploitation: Novel monomethylauristatin E and didesmethylauristatin E prodrugs were prepared, and in vitro and in vivo evaluations of the prodrugs using human and mouse cancer cell lines showed that they are less toxic and more efficacious than the parent cytotoxins, as their activation was catalyzed selectively by the cysteine protease, legumain, which is overexpressed in the active form in
肿瘤开发:制备了新型单甲基奥瑞他汀 E 和双去甲基奥瑞他汀 E 前药,并使用人和小鼠癌细胞系对前药进行了体外和体内评估,结果表明它们比母体细胞毒素毒性更小、更有效,因为它们的活化是选择性催化的通过半胱氨酸蛋白酶legumain,它在肿瘤微环境中以活性形式过度表达。